Synaptic transmission and the susceptibility of HIV infection to anti-viral drugs

Natalia L. Komarova, David Levy, Dominik Wodarz

Research output: Contribution to journalArticle

Abstract

Cell-to-cell viral transmission via virological synapses has been argued to reduce susceptibility of the virus population to anti-viral drugs through multiple infection of cells, contributing to low-level viral persistence during therapy. Using a mathematical framework, we examine the role of synaptic transmission in treatment susceptibility. A key factor is the relative probability of individual virions to infect a cell during free-virus and synaptic transmission, a currently unknown quantity. If this infection probability is higher for free-virus transmission, then treatment susceptibility is lowest if one virus is transferred per synapse, and multiple infection of cells increases susceptibility. In the opposite case, treatment susceptibility is minimized for an intermediate number of virions transferred per synapse. Hence, multiple infection via synapses does not simply lower treatment susceptibility. Without further experimental investigations, one cannot conclude that synaptic transmission provides an additional mechanism for the virus to persist at low levels during anti-viral therapy.

Original languageEnglish (US)
Article number2103
JournalScientific Reports
Volume3
DOIs
StatePublished - 2013

Fingerprint

Synaptic Transmission
HIV Infections
Synapses
Viruses
Pharmaceutical Preparations
Infection
Virion
Therapeutics
Population

ASJC Scopus subject areas

  • General
  • Medicine(all)

Cite this

Synaptic transmission and the susceptibility of HIV infection to anti-viral drugs. / Komarova, Natalia L.; Levy, David; Wodarz, Dominik.

In: Scientific Reports, Vol. 3, 2103, 2013.

Research output: Contribution to journalArticle

@article{116ca30322fa428abd803ae9b5d3ee70,
title = "Synaptic transmission and the susceptibility of HIV infection to anti-viral drugs",
abstract = "Cell-to-cell viral transmission via virological synapses has been argued to reduce susceptibility of the virus population to anti-viral drugs through multiple infection of cells, contributing to low-level viral persistence during therapy. Using a mathematical framework, we examine the role of synaptic transmission in treatment susceptibility. A key factor is the relative probability of individual virions to infect a cell during free-virus and synaptic transmission, a currently unknown quantity. If this infection probability is higher for free-virus transmission, then treatment susceptibility is lowest if one virus is transferred per synapse, and multiple infection of cells increases susceptibility. In the opposite case, treatment susceptibility is minimized for an intermediate number of virions transferred per synapse. Hence, multiple infection via synapses does not simply lower treatment susceptibility. Without further experimental investigations, one cannot conclude that synaptic transmission provides an additional mechanism for the virus to persist at low levels during anti-viral therapy.",
author = "Komarova, {Natalia L.} and David Levy and Dominik Wodarz",
year = "2013",
doi = "10.1038/srep02103",
language = "English (US)",
volume = "3",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Synaptic transmission and the susceptibility of HIV infection to anti-viral drugs

AU - Komarova, Natalia L.

AU - Levy, David

AU - Wodarz, Dominik

PY - 2013

Y1 - 2013

N2 - Cell-to-cell viral transmission via virological synapses has been argued to reduce susceptibility of the virus population to anti-viral drugs through multiple infection of cells, contributing to low-level viral persistence during therapy. Using a mathematical framework, we examine the role of synaptic transmission in treatment susceptibility. A key factor is the relative probability of individual virions to infect a cell during free-virus and synaptic transmission, a currently unknown quantity. If this infection probability is higher for free-virus transmission, then treatment susceptibility is lowest if one virus is transferred per synapse, and multiple infection of cells increases susceptibility. In the opposite case, treatment susceptibility is minimized for an intermediate number of virions transferred per synapse. Hence, multiple infection via synapses does not simply lower treatment susceptibility. Without further experimental investigations, one cannot conclude that synaptic transmission provides an additional mechanism for the virus to persist at low levels during anti-viral therapy.

AB - Cell-to-cell viral transmission via virological synapses has been argued to reduce susceptibility of the virus population to anti-viral drugs through multiple infection of cells, contributing to low-level viral persistence during therapy. Using a mathematical framework, we examine the role of synaptic transmission in treatment susceptibility. A key factor is the relative probability of individual virions to infect a cell during free-virus and synaptic transmission, a currently unknown quantity. If this infection probability is higher for free-virus transmission, then treatment susceptibility is lowest if one virus is transferred per synapse, and multiple infection of cells increases susceptibility. In the opposite case, treatment susceptibility is minimized for an intermediate number of virions transferred per synapse. Hence, multiple infection via synapses does not simply lower treatment susceptibility. Without further experimental investigations, one cannot conclude that synaptic transmission provides an additional mechanism for the virus to persist at low levels during anti-viral therapy.

UR - http://www.scopus.com/inward/record.url?scp=84880121275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880121275&partnerID=8YFLogxK

U2 - 10.1038/srep02103

DO - 10.1038/srep02103

M3 - Article

C2 - 23811684

AN - SCOPUS:84880121275

VL - 3

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 2103

ER -